aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
0.4900
-0.0385 (-7.28%)
At close: May 22, 2026, 4:00 PM EDT
0.4992
+0.0092 (1.88%)
After-hours: May 22, 2026, 7:59 PM EDT
aTyr Pharma Stock Forecast
ATYR's stock price has decreased by -86.93% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 9 analysts polled by S&P Global, aTyr Pharma stock has a consensus rating of "Buy" and an average price target of $2.86. The average 1-year stock price forecast is 483.67% higher than the current stock price, while the lowest is $1.00 (+104.08%) and the highest is $7.00 (+1,328.57%).
Price Target: $2.86 (+483.67%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for aTyr Pharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 8 | 8 | 8 | 8 | 8 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Freedom Broker | Freedom Broker | Hold → Strong Buy Upgrades $1 → $3.5 | Hold → Strong Buy | Upgrades | $1 → $3.5 | +614.29% | May 20, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $1.5 → $1 | Hold | Maintains | $1.5 → $1 | +104.08% | Nov 7, 2025 |
| Freedom Broker | Freedom Broker | Strong Buy → Hold Downgrades $9.5 → $1 | Strong Buy → Hold | Downgrades | $9.5 → $1 | +104.08% | Sep 19, 2025 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $25 → $1 | Buy → Hold | Downgrades | $25 → $1 | +104.08% | Sep 16, 2025 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $16 → $1.5 | Buy → Hold | Downgrades | $16 → $1.5 | +206.12% | Sep 16, 2025 |
Financial Forecast
Revenue This Year
n/a
from 190.00K
Revenue Next Year
n/a
EPS This Year
-0.57
from -0.80
EPS Next Year
-0.61
from -0.57
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||||
| Avg | n/a | n/a | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.35 | -0.29 | ||||||
| Avg | -0.57 | -0.61 | ||||||
| Low | -0.74 | -0.91 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.